Management Change/Compensation Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) On October 7, 2024, BioRegenx, Inc., a Nevada corporation ("BioRegenx") appointed Richard Janney to serve as a member of its board of directors until his successor is elected and qualified, or until he resigns or is removed.

There is no arrangement or understanding between Mr. Janney and any other person pursuant to which he was selected as a director. Mr. Janney is not currently a participate in any material plan, contract or arrangement with BioRegenx and has not received any grant or award pursuant to any such plan, contract or arrangement.

On October 7, 2024, the board formed an audit committee. Mr. Janney and Suzanne Bird (existing director of BioRegenx) were named to the audit committee.

Since the beginning fiscal 2023, there have not been any transactions, and there are not any currently proposed transactions, in which BioRegenx was, or is to be, a participant and in which Mr. Janney had, or will have, a direct or indirect material interest.